Sillence DJ ‘Simple sphingolipids in neurodegeneration’ HEIF Innovation, £15K (Oct 17-18) PI
Grootveld M., F. Platt, D. Sillence ‘Identification of New Biomarkers for the Metabolomics Classification of Batten Disease: A Drug-Targeting Strategy’ Beyond Batten Disease Foundation (Oct 2016-9), £120K Co-PI
Wheeler S and Sillence D ‘Modelling lysosomal storage diseases’ 51³Ô¹Ïapp High Flier studentship (Sept 2016-19), £45K PI
Silence DJ ‘Niemann Pick C and vATPase’ HEIF5 (sept 15- July 16) £1500
Grootveld M. D. Sillence, F. Platt, A. D’Azzo, C. Tifft, HEIF_5 Collaborative Award (2015-2016), £35K
Establishment and Operation of an Interdisciplinary Global Lysosomal Diseases Metabolomics Research Group (IGLDMRG) Sillence D (with T. Zetterstrom) 51³Ô¹Ïapp Fees-Only PhD Scholarship Award, 2014-2017, £12.5K
A role for sphingolipids in the action of anti-depressants Rushworth,J, Morris, M. Fretwell, L. Slater, A. Dunford,L. Grootveld, M. Sillence DJ, Ruparelia,K, Bhambra, A, Arroo R. (2014) Cell imaging and analysis facility RCIF2, £77,600
Grootveld, M, Sillence D., Platt, FM (2013) Identification of Novel Biomarker Patterns for the Metabolomic Classification of Niemann-Pick Disease C and Response to Treatment SPARKS, £51,000
Sillence D, Grootveld M (2013) Identification of Novel Biomarker Patterns for the Metabolomic Classification of Niemann-Pick Disease C and its Response to Treatment Small Projects Scheme, £5,000 Co-PI
Assay of sphingomyelinase inhibitors, Off-Label Ltd/Penn Ltd, research project, July 2008 – Nov 2008, PI.